134 related articles for article (PubMed ID: 31954519)
1. IC261 suppresses progression of hepatocellular carcinoma in a casein kinase 1 δ/ε independent manner.
Yuan F; Li D; Guo M; Fang T; Sun J; Qi F; Rao Q; Zhao Z; Huang P; Yang B; Xia J
Biochem Biophys Res Commun; 2020 Mar; 523(3):809-815. PubMed ID: 31954519
[TBL] [Abstract][Full Text] [Related]
2. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.
Cheong JK; Nguyen TH; Wang H; Tan P; Voorhoeve PM; Lee SH; Virshup DM
Oncogene; 2011 Jun; 30(22):2558-69. PubMed ID: 21258417
[TBL] [Abstract][Full Text] [Related]
3. IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer.
Liu M; Hu Y; Lu S; Lu M; Li J; Chang H; Jia H; Zhou M; Ren F; Zhong J
Int J Biol Sci; 2020; 16(5):882-892. PubMed ID: 32071557
[TBL] [Abstract][Full Text] [Related]
4. Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo.
Brockschmidt C; Hirner H; Huber N; Eismann T; Hillenbrand A; Giamas G; Radunsky B; Ammerpohl O; Bohm B; Henne-Bruns D; Kalthoff H; Leithäuser F; Trauzold A; Knippschild U
Gut; 2008 Jun; 57(6):799-806. PubMed ID: 18203806
[TBL] [Abstract][Full Text] [Related]
5. IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects.
Behrend L; Milne DM; Stöter M; Deppert W; Campbell LE; Meek DW; Knippschild U
Oncogene; 2000 Nov; 19(47):5303-13. PubMed ID: 11103931
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta.
Höttecke N; Liebeck M; Baumann K; Schubenel R; Winkler E; Steiner H; Schmidt B
Bioorg Med Chem Lett; 2010 May; 20(9):2958-63. PubMed ID: 20350806
[TBL] [Abstract][Full Text] [Related]
7. Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth.
Greer YE; Rubin JS
J Cell Biol; 2011 Mar; 192(6):993-1004. PubMed ID: 21422228
[TBL] [Abstract][Full Text] [Related]
8. Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.
Monastyrskyi A; Nilchan N; Quereda V; Noguchi Y; Ruiz C; Grant W; Cameron M; Duckett D; Roush W
Bioorg Med Chem; 2018 Feb; 26(3):590-602. PubMed ID: 29289448
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
[TBL] [Abstract][Full Text] [Related]
10. Microtubules depolymerization caused by the CK1 inhibitor IC261 may be not mediated by CK1 blockage.
Stöter M; Krüger M; Banting G; Henne-Bruns D; Knippschild U
PLoS One; 2014; 9(6):e100090. PubMed ID: 24937750
[TBL] [Abstract][Full Text] [Related]
11. State-dependent block of voltage-gated sodium channels by the casein-kinase 1 inhibitor IC261.
Föhr KJ; Knippschild U; Herkommer A; Fauler M; Peifer C; Georgieff M; Adolph O
Invest New Drugs; 2017 Jun; 35(3):277-289. PubMed ID: 28164251
[TBL] [Abstract][Full Text] [Related]
12. Casein kinase 1δ activity: a key element in the zebrafish circadian timing system.
Smadja Storz S; Tovin A; Mracek P; Alon S; Foulkes NS; Gothilf Y
PLoS One; 2013; 8(1):e54189. PubMed ID: 23349822
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest.
Yang WS; Stockwell BR
Genome Biol; 2008; 9(6):R92. PubMed ID: 18518968
[TBL] [Abstract][Full Text] [Related]
14. N-(1H-Pyrazol-3-yl)quinazolin-4-amines as a novel class of casein kinase 1δ/ε inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Karthikeyan C; Jharia P; Waiker DK; Nusbaum AC; Amawi H; Kirwen EM; Christman R; Arudra SKC; Meijer L; Tiwari AK; Trivedi P
Bioorg Med Chem Lett; 2017 Jun; 27(12):2663-2667. PubMed ID: 28487075
[TBL] [Abstract][Full Text] [Related]
15. Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes.
Meng QJ; Maywood ES; Bechtold DA; Lu WQ; Li J; Gibbs JE; Dupré SM; Chesham JE; Rajamohan F; Knafels J; Sneed B; Zawadzke LE; Ohren JF; Walton KM; Wager TT; Hastings MH; Loudon AS
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15240-5. PubMed ID: 20696890
[TBL] [Abstract][Full Text] [Related]
16. Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival.
Varghese RT; Young S; Pham L; Liang Y; Pridham KJ; Guo S; Murphy S; Kelly DF; Sheng Z
Sci Rep; 2018 Sep; 8(1):13621. PubMed ID: 30206363
[TBL] [Abstract][Full Text] [Related]
17. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of casein kinase I delta alters mitotic spindle formation and induces apoptosis in trophoblast cells.
Stöter M; Bamberger AM; Aslan B; Kurth M; Speidel D; Löning T; Frank HG; Kaufmann P; Löhler J; Henne-Bruns D; Deppert W; Knippschild U
Oncogene; 2005 Dec; 24(54):7964-75. PubMed ID: 16027726
[TBL] [Abstract][Full Text] [Related]
19. Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.
Janovska P; Verner J; Kohoutek J; Bryjova L; Gregorova M; Dzimkova M; Skabrahova H; Radaszkiewicz T; Ovesna P; Vondalova Blanarova O; Nemcova T; Hoferova Z; Vasickova K; Smyckova L; Egle A; Pavlova S; Poppova L; Plevova K; Pospisilova S; Bryja V
Blood; 2018 Mar; 131(11):1206-1218. PubMed ID: 29317454
[TBL] [Abstract][Full Text] [Related]
20. 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε.
Bischof J; Leban J; Zaja M; Grothey A; Radunsky B; Othersen O; Strobl S; Vitt D; Knippschild U
Amino Acids; 2012 Oct; 43(4):1577-91. PubMed ID: 22331384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]